Aptevo Therapeutics is Biotechnology in United States that focus on Aptevo Therapeutics Inc business. Founded in 2016. They cover business area such as Aptevo Therapeutics Inc, novel immunotherapeutic candidate, different form, cancer, its drug candidate, its ADAPTIR platform, its pipeline, t-cell cytotoxicity, mesothelioma, non-small-cell-lung, head, neck.
2016
( 8 years old in 2024 )
Aptevo Therapeutics Inc
-
2401 4th Avenue
Suite 1050
Seattle, WA 98121
United States
Private
Aptevo Therapeutics Incnovel immunotherapeutic candidatedifferent formcancerits drug candidateits ADAPTIR platformits pipelinet-cell cytotoxicitymesothelioma, non-small-cell-lungheadneck
* We use standard office opening hours in near Aptevo Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aptevo Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Aptevo Therapeutics business is focusing on Aptevo Therapeutics Inc.
Aptevo Therapeutics headquarter office and corporate office address is located in 2401 4th Avenue Suite 1050 Seattle, WA 98121 United States.
Aptevo Therapeutics was founded in United States.
In 2024, Aptevo Therapeutics is currently focus on Aptevo Therapeutics Inc sector.
Above is snippet of Google Trends for "Aptevo Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aptevo Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
